November 1, 2006Expert Review of Cardiovascular Therapy
Genetic basis of hypertrophic cardiomyopathy
Population
Patients with hypertrophic cardiomyopathy (HCM)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports genetic counseling in HCM families; leaves open non-sarcomere causes in remaining cases.
Key Points
- This research aims to explore the genetic mutations responsible for hypertrophic cardiomyopathy and their impact on disease mechanisms.
- Identification of mutations in 13 sarcomere-related genes linked to hypertrophic cardiomyopathy.
- Assessment of the mutation pick-up rate through genetic screening.
- Investigation of modifying factors influencing clinical phenotype.
- Over 250 mutations have been identified, with a mutation pick-up rate of up to 60%.
- Current studies are ongoing to discover additional causative genes.
- Research objectives focus on enhancing understanding of HCM pathogenesis for better diagnostics and therapies.
Structured PICO
P
Population
Patients with hypertrophic cardiomyopathy (HCM)
This review highlights the genetic basis of hypertrophic cardiomyopathy, emphasizing that over 250 mutations in 13 sarcomere-related genes have been identified, with genetic screening yielding a mutation pick-up rate of up to 60%.
Cite This Study
Lind et al. (2006) studied this question.